Laurent Yvan-Charvet

WORK HISTORY

EDUCATION

SKILLS

ABOUT LAURENT YVAN-CHARVET

Dr. Laurent Yvan-Charvet obtained his Ph.D. in Endocrinology in 2005 from the University of Paris XI, France. He was the recipient of the Roger Davis Award in 2010, finalist of the I.H. Page Young Investigator Award in 2011, the recipient of the EAS young Investigator award in 2013 and the Daniel Steinberg Early Career Invest. Award at the AHA in 2015.His research work at Columbia University mainly focused on how the cholesterol efflux potential of HDL-cholesterol (good cholesterol) could boost your immune system with potential benefits on acute and chronic inflammatory diseases. Therapies aimed at raising HDL-C are currently under Phase clinical trials to treat cardiometaboic diseases.After a contribution to the development of new therapeutics for cardiovascular diseases at Pfizer, his current research interest as a group leader lies in immune and hematopoietic cell metabolism in diseases.Our research program primarily focuses on the ‘Metabolism of the immune and hematopoietic systems in cancer and cardiometabolic diseases with the aim to gain insight in immune metabolic complications observed in these diseases. We are currently focusing on the identification of novel metabolic pathways that could act independently or in synergy on the metabolism of immune and hematopoietic systems in myeloproliferative disease, lung cancer and cardiometabolic diseases.The team is dedicated to achieve a deeper understanding of the metabolism of the immune and hematopoietic system in cancer and cardiometabolic diseases with the hope of identifying new candidate targets for therapeutic interventions or new predictors of disease outcomes.